Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Qi Chun Cai"'
Autor:
Vikneswari Rajasegaran, Chee Leong Cheng, Junhun Cho, Lay Poh Khoo, Huangming Hong, Daryl Tan, Daryl Ming Zhe Cheah, Dachuan Huang, Rou-Jun Peng, Jeslin Chian Hung Ha, Jing Quan Lim, Yeow Tee Goh, Burton Kuan Hui Chia, Seok Jin Kim, Tiffany Tang, Olaf Rötzschke, Eric Tse, Choon Kiat Ong, Won Seog Kim, Maarja-Liisa Nairismagi, Yok-Lam Kwong, Qingqing Cai, Colin Phipps, Yurike Laurensia, Jing Tan, Yvonne Loh, Jin-Xin Bei, Soon Thye Lim, Tongyu Lin, Benjamin Mow, Qi-Chun Cai, Johnathan Xiande Lim, Rex Au-Yeung, Cedric Chuan Young Ng, Esther Kam Yin Wong, Thomas S. Y. Chan, Li-Mei Poon, Jason Yongsheng Chan, Nicholas Francis Grigoropoulos, Jabed Iqbal, William Hwang
Publikováno v:
Leukemia. 34:3413-3419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73bb690d267f2d46a2bd3b2eaf660cbf
https://doi.org/10.1038/s41375-020-1000-0
https://doi.org/10.1038/s41375-020-1000-0
Autor:
Hai-Jun Wen, Pei Lin, Gong-Xun Zhong, Zhi-Chao Xu, Lei Shuai, Zhi-Yuan Wen, Chong Wang, Xue Cao, Wen-Bin He, Jing Feng, Qi-Chun Cai, Hua-Juan Ma, Si-Jin Wu, Guo-Dong Wang, Xue-Mei Lyu, Feng-Liang Liu, Yong-Tang Zheng, Hui Zeng, Xiong-Lei He, Hualan Chen, Fu-Jie Zhang, Chung-I Wu
In the search for treatment schemes of COVID-19, we start by examining the general weakness of coronaviruses and then identify approved drugs attacking that weakness. The approach, if successful, should identify drugs with a specific mechanism that i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d5978a040023e42cdd80a1340382afd
https://doi.org/10.1101/2021.04.16.440104
https://doi.org/10.1101/2021.04.16.440104
Autor:
Chee Leong Cheng, Daryl Tan, Nicholas Francis Grigoropoulos, Jason Yongsheng Chan, Yurike Laurensia, Tiffany Tang, Qi-Chun Cai, Daryl Ming Zhe Cheah, Thomas S. Y. Chan, Jing Quan Lim, Qingqing Cai, Benjamin Mow, Eric Tse, Yok-Lam Kwong, Soon Thye Lim, Vikneswari Rajasegaran, Lay Poh Khoo, Jing Tan, Won Seog Kim, Yvonne Loh, William Hwang, Dachuan Huang, Rex Au-Yeung, Seok Jin Kim, Li-Mei Poon, Junhun Cho, Cedric Chuan Young Ng, Rou-Jun Peng, Jeslin Chian Hung Ha, Colin Phipps, Johnathan Xiande Lim, Esther Kam Yin Wong, Jabed Iqbal, Burton Kuan Hui Chia, Yeow Tee Goh, Huangming Hong, Choon Kiat Ong, Jin-Xin Bei, Olaf Rötzschke, Maarja-Liisa Nairismagi, Tongyu Lin
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317b99a6c310a213eb5a0c04631fa785
https://europepmc.org/articles/PMC8182767/
https://europepmc.org/articles/PMC8182767/
Autor:
Feng-Liang Liu, Ming Xing Huang, Zi Feng Yang, Hai Jun Wen, Fei Xiao, Rong Hua Luo, Jing Feng, Xi Zhou, Hong Shan, Fang Liang Chen, Chung-I Wu, Hua Juan Ma, Ding Yu Zhang, Qi Chun Cai, Jianxing He, Wen Bin He, Yong-Tang Zheng, Xue Mei Lyu, You Shang
Publikováno v:
National Science Review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874dc68d9d11129f199f0bea3d983d47
https://pubmed.ncbi.nlm.nih.gov/34676091
https://pubmed.ncbi.nlm.nih.gov/34676091
Autor:
Bing, Bai, Xiao-Xiao, Wang, Yan, Gao, Peng-Fei, Li, Hai-Xia, He, Li-Qin, Ping, Cheng, Huang, Qi-Chun, Cai, Hui-Qiang, Huang
Publikováno v:
Bone marrow transplantation. 56(5)
Peri-engraftment respiratory distress syndrome (PERDS) is a kind of potentially life-threatening complication of autologous stem cell transplantation (ASCT). PERDS is characterized by fever, dyspnea, and hypoxemia during neutrophil engraftment. In or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3fcfa9a4c1670e4d762fa2d0ba6be50
https://pubmed.ncbi.nlm.nih.gov/33273659
https://pubmed.ncbi.nlm.nih.gov/33273659
Autor:
J. Chen, J. Lim, Y. Guo, T. K. Chan, W. Hwang, P. Rou-Jun, L. Feng, Daryl Tan, Jing Tan, Qi-Chun Cai, T. Tang, Chee-Leong Cheng, W. Pang, B. Teh, Yurike Laurensia, Jin-Xin Bei, Wee Joo Chng, Soon Thye Lim, D. Huang, Olaf Rötzschke, Burton Kuan Hui Chia, S. Ng, Yeow Tee Goh, B. Han, Puay Hoon Tan, Chiea Chuen Khor, D. Cheah, Tongyu Lin, Steven G. Rozen, C. Ong, Rex Au-Yeung, Huangming Hong, C. Ng, YL Kwong, Thomas Tousseyn
Publikováno v:
Hematological Oncology. 37:203-204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de56ac251401442c2f5c43d8761a9ee5
https://doi.org/10.1002/hon.19_2630
https://doi.org/10.1002/hon.19_2630
Publikováno v:
Expert Opinion on Drug Safety. 14:21-29
To evaluate the safety and efficacy of rapid rituximab infusion (RRI) plus chemotherapy in patients with CD20(+) non-Hodgkin's lymphoma (NHL).A total of 177 patients received 4 - 6 cycles of rituximab-based chemotherapy. The first cycle was given wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e8c8ae776fb37c13729f2a2ee5f4a6
https://doi.org/10.1517/14740338.2015.988138
https://doi.org/10.1517/14740338.2015.988138
Publikováno v:
Expert Opinion on Pharmacotherapy. 15:163-171
Although cisplatin combined with 5-fluorouracil is a common first-line regimen for advanced nasopharyngeal carcinoma (NPC), there are no standard regimens for refractory or relapsed patients. A study of DXD regimen [cisplatin (D), capecitabine (X) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53aabe65b189d4e1c8f35078a2ef43d5
https://doi.org/10.1517/14656566.2014.866652
https://doi.org/10.1517/14656566.2014.866652
Autor:
Su Xia Lin, Yan Gao, Hui Qiang Huang, Jia Bin Lu, Yi Xia, Hong Liao, Xiao Xaio Wang, Ze Xiao Lin, Qi Chun Cai
Publikováno v:
Medical Oncology. 29:2317-2322
Diffuse large B-cell lymphoma (DLBCL) is characterized by its clinical and biological heterogeneity. Although the International Prognostic Index (IPI) provides a clinical model for risk stratification of patients with DLBCL, notable variability in ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46a63d7386d713085f36adf1c8fa9ccd
https://doi.org/10.1007/s12032-011-0123-6
https://doi.org/10.1007/s12032-011-0123-6
Autor:
Daryl Tan, Benjamin Mow, Jing Quan Lim, Jabed Iqbal, Soon Thye Lim, Yurike Laurensia, Yok-Lam Kwong, Li-Mei Poon, Tiffany Tang, Dachuan Huang, Tongyu Lin, Cedric Chuan Young Ng, Jin-Xin Bei, Qi-Chun Cai, Tammy Song, Rex Au-Yeung, Choon Kiat Ong, Burton Chia Kuan Hui, Huangming Hong
Publikováno v:
Blood. 132:2915-2915
The genetic landscape of Natural killer/T-cell nasal-type lymphoma (NKTL) has been recently unraveled by discoveries describing recurring mutations altering the JAK-STAT pathway, epigenetic modifiers, the DDX3X gene and genetic predisposition in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c47c9d2a163706e4705f616bcc04bbc1
https://doi.org/10.1182/blood-2018-99-110900
https://doi.org/10.1182/blood-2018-99-110900